BSX · NYSE · STOCK
Boston Scientific (BSX) Stock Analysis
$49.39
52W $42.20 – $109.50
62/100
$72.85B
19.8
0.57
Is BSX Bullish or Bearish?
Bullish.
Innellis AI committee rates Boston Scientific (BSX) Buy with a composite score of 62/100
, based on 5 analysts with 60% agreement.
Last updated August 25, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.17 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.83 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 17.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- News sentiment is positive (+0.33 across 25 articles, 14d) — News
Bear Case
- Bollinger bandwidth of 17.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 25, 2026
Overall Committee Score
62/100
Agreement
60%
Analysts
5
Conviction
Contested
Sector Rank
Top 23%
of 192 Healthcare peers
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 17.9% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 25 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Investment Thesis Evolution
Committee score moved marginally from 59.8 to 61.8.
- Committee agreement increased notably from 50% to 60%.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 1 signal(s) disappeared.
- Analyst(s) abstained: Value Analyst.
Analyst-level changes:
- Growth Analyst: score 79->82 (+4).
- Value Analyst abstained (was neutral at 53).
Comparing 2026-08-24 to 2026-08-25 (1 day apart).
Technical Analysis
RSI (14)
43.9
Neutral
MACD Histogram
-0.147
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$48.37
Resistance
$54.74
Bollinger %B
0.45
Inside Bands
Price vs Moving Averages
EMA 9
$50.19
Below
EMA 21
$49.22
Above
EMA 50
$48.96
Above
EMA 200
$64.53
Below
Fundamental Analysis
Valuation
86
Growth
78
Profitability
78
Financial Health
68
Cash Flow
70
Valuation
P/E Ratio
19.8×
P/B Ratio
2.90×
PEG Ratio
0.43
Dividend Yield
0.00%
52W High
$109.50
52W Low
$42.20
Quality & Growth
ROE
1190.9%
ROA
660.8%
Gross Margin
7115.6%
Operating Margin
2146.1%
Revenue Growth YoY
—
Debt / Equity
0.51
AI Fundamental Assessment
P/E ratio of 19.8 (inexpensive relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.9%; Return on assets of 6.6%; Net margin of 17.5%; Gross margin of 71.2%; Current ratio of 1.24 (tight short-term liquidity); Debt-to-equity of 0.51; Free cash flow per share is positive (2.45); Most recent quarter beat estimates by 2.9%; 5 consecutive earnings beats; EPS growth accelerating (+0.0% -> +7.5% QoQ); Average YoY EPS growth of 14.7%; Analyst estimates rising over recent quarters
Get the Full BSX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →